Skip to main navigation

Our Science
AT-527
COVID-19
About Atea
Investors
Careers
Contact

The tip of a pipette pointing towards droplets suspended in a green solution.

Investor Relations

Board of Directors

Breadcrumb

Investors
Board of Directors

Board of Directors

Jean-Pierre Sommadossi, PhD

Chairman & CEO, Atea Pharmaceuticals

Read More

Jerome Adams, M.D., M.P.H.

Former Surgeon General of the United States

Read More

Member of the Nominating and Corporate Governance Committee

Chair of the Strategy and Public Policy Committee

Franklin Berger

Founding & Managing Director, FMB Research

Read More

Member of the Audit Committee

Chair of the Compensation Committee

Barbara Duncan

Former CFO, Intercept Pharmaceuticals

Read More

Chair of the Audit Committee

Member of the Nominating and Corporate Governance Committee

Bruno Lucidi

Life Sciences Expert, Wallonia Trade and Foreign Investment Agency (AWEX)

Read More

Member of the Compensation Committee

Member of the Audit Committee

Polly A. Murphy, D.V.M., Ph.D.

Chief Business Officer, Urogen Pharma

Read More

Chair of the Nominating and Corporate Governance Committee

Member of the Strategy and Public Policy Committee

Bruce Polsky, M.D

Professor and Chairman, Department of Medicine, NYU Langone Hospital – Long Island; Assoc. Dean, Faculty, NYU Long Island School of Medicine

Read More

Member of the Compensation Committee

Member of the Strategy and Public Policy Committee

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

Atea Pharmaceuticals, Inc.
225 Franklin Street
Suite 2100
Boston, MA 02110
(857) 284-8891

Copyright © 2022 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use